Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. (Q40265316)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 June 2006

Language	Label	Description	Also known as
English	Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D.	scientific article published on 19 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Hui L

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Zheng Y

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yan Y

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Bargonetti J

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Foster DA

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

19 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

7305-7310

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Phospholipase D confers rapamycin resistance in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Alternative phospholipase D/mTOR survival signal in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Gain of function mutations in p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Phosphatidic acid-mediated mitogenic activation of mTOR signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Targeting Phospholipase D-mediated Survival Signals in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Tumor-derived p53 mutant C174Y is a gain-of-function mutant which activates the fos promoter and enhances colony formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Modulation of gene expression by tumor-derived p53 mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Role for phospholipase D in receptor-mediated endocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the biological activities of wild-type and mutant p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1209735

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40265316&oldid=2203552425"